An Open Label Randomized Phase IV Study of the Safety and Efficacy of ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2016
At a glance
- Drugs Corticotropin (Primary)
- Indications Lupus nephritis
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 28 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2018, according to ClinicalTrials.gov record.
- 11 Sep 2013 Planned End Date changed from 1 Jul 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.